Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.8 USD | -3.23% | -8.63% | -38.98% |
09/05 | BioXcel Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
09/05 | Transcript : BioXcel Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.98% | 6.72Cr | |
+8.38% | 11TCr | |
+10.13% | 10TCr | |
-11.69% | 2.25TCr | |
+1.05% | 2.26TCr | |
-11.07% | 1.8TCr | |
-41.90% | 1.65TCr | |
-16.00% | 1.58TCr | |
+2.28% | 1.35TCr | |
+20.54% | 1.1TCr |
- Stock Market
- Equities
- BTAI Stock
- News BioXcel Therapeutics, Inc.
- Guggenheim Adjusts Price Target on BioXcel Therapeutics to $46 From $50, Maintains Buy Rating